Eli Lilly (LLY) Operating Margin Growth (5y) (2014 - 2026)

Eli Lilly (LLY) Operating Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2,642.00
Dec 31, 2025 1,298.00
Sep 30, 2025 2,331.00
Jun 30, 2025 1,897.00
Mar 31, 2025 1,334.00
Dec 31, 2024 1,406.00
Sep 30, 2024 1,051.00
Jun 30, 2024 721.00
Mar 31, 2024 619.00
Dec 31, 2023 695.00
Sep 30, 2023 938.00
Jun 30, 2023 -180.00
Mar 31, 2023 -428.00
Dec 31, 2022 855.00
Sep 30, 2022 467.00
Jun 30, 2022 398.00
Mar 31, 2022 1,274.00
Dec 31, 2021 1,114.00
Sep 30, 2021 1,135.00
Jun 30, 2021 330.00